We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





Lab-in-a-Backpack Offers Fast, Affordable, Reliable COVID-19 Testing

By LabMedica International staff writers
Posted on 28 Jan 2022

Researchers have created a simple COVID-19 testing lab that fits into a backpack providing a cheap and effective solution for low income or remote areas. More...

In a new study, scientists from Queen Mary University of London (London, UK) have shown that their lab-in-a-backpack approach is as effective as commercially available COVID-19 tests at detecting SARS-CoV-2. The compact kit is relatively inexpensive to make, costing USD 51 in total. It could offer an alternative testing solution for resource-poor countries or remote areas with little access to well-equipped testing labs or trained personnel to process samples. The testing kit is based on a simple, non-invasive COVID-19 LAMP test and uses low-cost hardware, including a centrifuge made from recycled computer hard drives, called a CentriDrive, to process samples.

The LAMP test is a widely accepted alternative to the commonly used PCR test, has a similar sensitivity but unlike the PCR test does not require temperature cycling, only a single high temperature to amplify any potential virus RNA. This allows the test to be performed with only minimal equipment and reagents. Because the LAMP test uses saliva samples, it also avoids the need for invasive, uncomfortable nasal swabs. However, the high costs of commercially available LAMP tests, as well as the expensive lab equipment required to run them, means that current commercial approaches aren’t suitable for remote locations, or in-home testing.

According to the researchers, the next steps will include making the kit instructions even more understandable so that people can use them regardless of their experience or language, as well as validating the kit with real patient samples. So, whilst this approach holds promise, further work is needed before the system can be implemented in real-world environments.

“In this study, using the LAMP test method in combination with a low-cost centrifuge, we provided an inexpensive, rapid and accurate method for the detection of COVID-19,” said Emily Lin, lead author of the study. “It will not only provide a viable and inexpensive test kit for regions such as Africa, where innovative solutions are particularly important during the Covid-19 pandemic. It can also be used in resource-rich areas, for example, in high school classrooms to demonstrate how to test for COVID-19.”

“We are excited for the potential of this mobile lab to do COVID-19 tests and the possibility to democratize access to inexpensive testing technology,” said Professor Stoyan Smoukov, Professor of Chemical Engineering at Queen Mary University of London. “It is made possible by our philosophy of creating low-cost instruments whenever possible from advances in electronics, or existing instruments.”

“Reuse is a high-value option for energy and materials sustainability, and we are glad that rather than exporting electronics waste to developing countries, we can export ways to empower people and turn waste computer hard drives into a centrifuge. The COVID-19 test is a timely application, but we also believe with this CentriDrive kit people could perform a large array of routine blood and urine tests, providing a centrifuge away from central hospital facilities,” added Professor Smoukov.

Related Links:
Queen Mary University of London 


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.